ClinVar Miner

Submissions for variant NM_002524.5(NRAS):c.191_196dup (p.Ser65_Ala66insAspSer)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Clinical Genomics Laboratory, Washington University in St. Louis RCV003458960 SCV004176912 likely pathogenic Pyogenic granuloma 2023-09-08 criteria provided, single submitter clinical testing The NRAS c.191_196dup (p.Ser65_Ala66insAspSer) variant was identified at an allelic fraction consistent with somatic origin and, to our knowledge, has not been reported in the medical literature. This variant is absent from the general population (gnomAD v.3.1.2), indicating it is not a common variant. NRAS c.191_196dup (p.Ser65_Ala66insAspSer) resides within a region, amino acids 59-67, of NRAS that is defined as a critical functional domain (Schubbert S et al., PMID: 17384584). Computational predictors are uncertain as to the impact of this variant on NRAS function. This variant is predicted to cause a change in the length of the protein due to an in-frame duplication of 2 amino acids in a non-repeat region. Based on an internally-developed protocol informed by the ACMG/AMP guidelines (Richards S et al., PMID: 25741868) and gene-specific practices from the ClinGen RASopathy Expert Panel Specification Registry, the NRAS c.191_196dup (p.Ser65_Ala66insAspSer) variant is classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.